Advertisment ACS-IndiaSymposium
Journal of Pharmaceutical Negative Results
  Print this page Email this page Small font sizeDefault font sizeIncrease font size 
Search Article 
Advanced search 
 Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts  

  About Us

  About the Journal

Journal of Pharmaceutical Negative Results ( [ISSN: Print -0976-9234, Online - 2229-7723] – An official publication of Phcog.Net. The journal is a peer-reviewed journal developed to publish original, innovative and novel research articles resulting in negative results. This peer-reviewed scientific journal publishes a theoretical and empirical paper that reports the negative findings and research failures in pharmaceutical field. Submissions should have a negative focus, which means the outputs of research yielded in negative results are being given more preference. All theoretical and methodological perspectives are welcomed. We also encourage the submission of short papers/communications presenting counter-examples to usually accepted conjectures or to published papers. This Journal is a biannual publication.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
Emerging Sources Citation Index, Index Copernicus, Scimago Journal Ranking, SCOPUS, Web of Science

Emerging Sources Citation Index 

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.


While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

About Phcog.Net

About Phcog.Net

Our mission at Phcog.Net is to provide accurate and latest information for a wide range of STM (science, technology and medcine) researchers across the globe, using quality journals and databases with cost-effective best practices. "Our main vision is to bring Pharmacy, Medicine and related field researchers together in a single platform and to develop interdisciplinary network of researchers."


  • To provide specific information upon request for faculty, researchers, and students involved in STM research.
  • To develop a web portal providing basic screening information for drugs, plant extracts, with further links to useful resources.
  • To facilitate the dissemination of information regarding techniques and methods involved in STM research.
  • To advance the quality of research in the field of STM.
  • To work collaboratively with R&D centers and industries and to describe their contributions in the field of STM.
  • To establish a discussion group to address difficulties and problems in respective research.
  • To provide documentation and information services such as library search/database search facilities including web-based information retrieval.

To develop close co-operation among national libraries/other information centers for the exchange of information and resource sharing in science, technology and medicine.

Aim and Scope

The main aim of the journal to publish the negative results so that newer generation of researchers should not waste their time and money repeating the same studies and finding the same unpublishable results. Most of the journals have published only the positive results and findings. However they do not publish negative results. We believe negative results are also a part of quality research.

    Medknow Publications   Top

  Editorial board